One of the key services FinVector offers is the aseptic filling of liquid investigational medicinal products (IMPs), or commercial products. This service is critical to support projects that require the supply of drug products for pre-clinical, Phase I, II and III clinical trials and for commercial use. This service operates from our manufacturing site in Finland, which is approved by the Finnish Medicines Agency (Fimea).
FinVector's aseptic filling services include:
FinVector has a dynamic packaging process which enables us to provide bespoke labelling and packaging options based on client need. The process consists of vial surface decontamination, inspection, labelling, secondary packaging into an individual dose-protective pot, and freezing of the pack to below -60 ºC. This regime is highly adaptive and we have produced multi-vial variants for client labelling at their distributor of choice. Client-specific labelling can be applied to the vials for a range of self-adhesive label types.